Estradiol alters nitric oxide production in the mouse aorta through the α-, but not β-, estrogen receptor

Circulation Research

Volumn 90, Issue 4, 2002, Pages 413-419

  Darblade, B ^a   Pendaries, C ^a   Krust, A ^b   Dupont, S ^b   Fouque, M J ^a   Rami, J ^a   Chambon, P ^b   Bayard, F ^a   Arnal, J F ^a  

^a CHU RANGUEIL   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Endothelial cell; Estrogen receptor; Estrogens; Nitric oxide synthase

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; CALCIMYCIN; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ESTRADIOL; ESTROGEN RECEPTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTROGEN THERAPY; FEMALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; THORACIC AORTA; UTERUS WEIGHT; VASCULAR RING;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA, THORACIC; BIOLOGICAL FACTORS; BODY WEIGHT; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; IONOPHORES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; OVARIECTOMY; RECEPTORS, ESTROGEN; UTERUS; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 0037040830     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/hh0402.105096     Document Type: Article

References (44)

1. International consensus conference on postmenopausal hormone therapy and the cardiovascular system
2. Cardioprotective effect of hormone replacement therapy: Is not due to selection bias
3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/progestin Replacement Study (HERS) Research Group
4. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
5. Effect of 17β estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits
6. Inhibition of coronary artery atherosclerosis by 17-β estradiol in ovariectomized monkeys: Lack of an effect of added progesterone
7. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys
8. Endothelium-derived relaxing and contracting factors
9. Endothelium-derived nitric oxide: Actions and properties
10. The L-arginine-nitric oxide pathway
11. Effects of 17β-estradiol on endothelium-dependent relaxation induced by acetylcholine in female rat aorta
12. 17β-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine
13. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
14. Effects of acute and chronic estrogenic treatment on vasomotor responses of aortic rings from ovariectomized rats
15. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta
16. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: Possible role of decreased endothelium-derived superoxide anion production
17. Induction of calcium-dependent nitric oxide synthases by sex hormones
18. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy
19. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: Implications for atherosclerosis
20. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine aortic endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production
21. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta: Gender difference and effect of estrogen receptor gene disruption
22. Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice
23. 2+ mobilization
24. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
25. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
26. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling
27. Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia
28. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae
29. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells: Effects on calcium sensitivity and NO release
30. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase
31. Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes
32. Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-α but not estrogen receptor-β
33. Effect of hypercholesterolemia on vascular reactivity in the rabbit: II, influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits
34. Regional differentiation in rat aorta: L-arginine metabolism and cGMP content in vitro
35. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice
36. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit
37. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo
38. 3-muscarinic acetylcholine receptors in the rat myometrium
39. Dynamic activation of endothelial nitric oxide synthase by Hsp90
40. Control of estrogen receptor ligand binding by Hsp90
41. Estrogen receptor null mice: What have we learned and where will they lead us?
42. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors α and β
43. Prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice
44. Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice